Erratum: Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 (Diabetologia DOI: 10.1007/s00125-011-2088-6);Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4

Diabetologia

Volumn 54, Issue 7, 2011, Pages 1630-1638

  Pham, M N ^a   Hawa, M I ^b   Pfleger, C ^a,c   Roden, M ^a   Schernthaner, G ^d   Pozzilli, P ^e   Buzzetti, R ^f   Scherbaum, W ^a   Seissler, J ^g   Kolb, H ^a   Hunter, S ^h   Leslie, R D G ^b   Schloot, N C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c BENAROYA RESEARCH INSTITUTE   (United States)

^d KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g UNIVERSITY OF MUNICH   (Germany)

^h ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Body mass index; Interleukin 1 receptor antagonist; Interleukin 10; Interleukin 6; Latent autoimmune diabetes in adults; Tumour necrosis factor alpha; Type 1 diabetes; Type 2 diabetes

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GENDER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES IN ADULT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 79959730659     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2375-2     Document Type: Erratum

References (45)

1. AE Butler J Janson Bonner-Weir R Ritzel RA Rizza PC Butler 2003 Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 102 110 12502499 10.2337/diabetes.52.1.102 1:CAS:528: DC%2BD3sXisVaisA%3D%3D (Pubitemid 36042113)
2. GS Hotamisligil 2006 Inflammation and metabolic disorders Nature 444 860 867 17167474 10.1038/nature05485 1:CAS:528:DC%2BD28XhtlShtrzK (Pubitemid 46024993)
3. SE Shoelson J Lee AB Goldfine 2006 Inflammation and insulin resistance J Clin Invest 116 1973 1801
4. JC Pickup MA Crook 1998 Is type 2 diabetes mellitus a disease of the innate immune system? Diabetologia 41 1241 1248 9794114 10.1007/s001250051058 1:CAS:528:DyaK1cXmtlais70%3D (Pubitemid 28449093)
5. JC Pickup MB Mattock GD Chusney D Burt 1997 NIDDM as a disease of the immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome Diabetologia 40 1286 1292 9389420 10.1007/s001250050822 1:CAS:528:DyaK2sXntFynsbc%3D (Pubitemid 27469668)
6. H Kolb T Mandrup-Poulsen 2005 An immune origin of type 2 diabetes? Diabetologia 48 1038 1050 15864529 10.1007/s00125-005-1764-9 1:CAS:528:DC%2BD2MXlt1KmtL4%3D (Pubitemid 40909636)
7. C Herder EJ Brunner W Rathmann, et al. 2009 Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study Diabetes Care 32 421 423 19073760 10.2337/dc08-1161
8. M Carstensen C Herder M Kivimäki, et al. 2010 Accelerated increase in serum interleukin-1 receptor antagonist (IL-1Ra) starts 6 years before diagnosis of type 2 diabetes: whitehall II prospective cohort study Diabetes 59 1222 1227 20185814 10.2337/db09-1199 1:CAS:528:DC%2BC3cXmtFegtr8%3D
9. C Herder A Zierer W Koenig M Roden C Meisinger B Thorand 2009 Transforming growth factor-beta 1 and incident type 2 diabetes: results from the MONICA/KORA case cohort study, 1984-2002 Diabetes Care 32 1921 1923 19592635 10.2337/dc09-0476 1:CAS:528:DC%2BD1MXhtlehs7bP
10. L He M He X Lv D Pu P Su Z Liu 2010 NF-kappaB binding activity and pro-inflammatory cytokines expression correlate with body mass index but not glycosylated haemoglobin in Chinese population Diab Res Clin Pract 90 73 80 10.1016/j.diabres.2010.06.016 1:CAS:528:DC%2BC3cXhtFajs77N
11. J Ventre T Doebber M Wu, et al. 1997 Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice Diabetes 46 1526 1531 9287059 10.2337/diabetes.46.9.1526 1:CAS:528: DyaK2sXlvFemsro%3D (Pubitemid 27369096)
12. GS Hotamisligil P Arner JF Caro RL Atkinson BM Spiegelman 1995 Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance J Clin Invest 95 2409 2415 7738205 10.1172/JCI117936 1:CAS:528:DyaK2MXltlWru70%3D
13. P Ziccardi F Nappo G Giugliano, et al. 2002 Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year Circulation 105 804 809 11854119 10.1161/hc0702.104279 1:CAS:528:DC%2BD38XitlOls7o%3D (Pubitemid 34174919)
14. B Vozarova C Weyer K Hanson PA Tataranni C Bogardus RE Pratley 2001 Circulating interleukin-6 relation to adiposity, insulin action, and insulin secretion Obes Res 97 414 417 10.1038/oby.2001.54 (Pubitemid 33603868)
15. CE Juge-Aubry E Somm A Pernin, et al. 2005 Adipose tissue is a regulated source of interleukin-10 Cytokine 29 270 274 15749027 1:CAS:528: DC%2BD2MXhvVSnt7c%3D (Pubitemid 40320927)
16. CE Juge-Aubry E Somm V Giusti, et al. 2003 Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation Diabetes 52 1104 1110 12716739 10.2337/diabetes.52.5.1104 1:CAS:528:DC%2BD3sXjsFGhtLY%3D (Pubitemid 36523343)
17. CM Larsen M Faulenbach A Vaag, et al. 2007 Interleukin-1-receptor antagonist in type 2 diabetes mellitus N Engl J Med 356 1517 1526 17429083 10.1056/NEJMoa065213 1:CAS:528:DC%2BD2sXkt1Sjtr4%3D (Pubitemid 46588416)
18. MA Atkinson GS Eisenbarth 2001 Type 1 diabetes: new perspectives on disease pathogenesis and treatment Lancet 358 221 229 11476858 10.1016/S0140-6736(01)05415-0 1:CAS:528:DC%2BD3MXltlymsr0%3D (Pubitemid 32718550)
19. R Tisch H McDevitt 1996 Insulin-dependent diabetes mellitus Cell 85 291 297 8616883 10.1016/S0092-8674(00)81106-X 1:CAS:528:DyaK28XivVyrsrc%3D (Pubitemid 26160699)
20. M Cnop N Welsh JC Jonas A Jörns S Lenzen DL Eizirik 2005 Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities Diabetes 54 Suppl.2 S97 S107 16306347 10.2337/diabetes.54. suppl-2.S97 1:CAS:528:DC%2BD2MXht12gs7nF (Pubitemid 43343337)
21. DL Eizirik ML Colli F Ortis 2009 The role of inflammation in insulitis and beta-cell loss in type 1 diabetes Nat Rev Endocrinol 5 219 226 19352320 10.1038/nrendo.2009.21 1:CAS:528:DC%2BD1MXjs1ymt7Y%3D
22. T Mandrup-Poulsen 1990 Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells Curr Top Microbiol Immunol 164 169 193 2073784 1:STN:280:DyaK3M7mtValtA%3D%3D (Pubitemid 20363433)
23. IL Campbell L Oxbrow LC Harrison 1991 Reduction in Insulitis following administration of IFN-gamma and TNF-alpha in the NOD mouse J Autoimm 4 249 262 10.1016/0896-8411(91)90022-5 1:STN:280:DyaK3MzlsVCnuw%3D%3D
24. F Nicoletti P Zaccone R Di Marco, et al. 1998 Paradoxical antidiabetogenic effect of gamma-interferon in DP-BB rats Diabetes 47 32 38 9421371 10.2337/diabetes.47.1.32 1:STN:280:DyaK1c%2FotFOhtg%3D%3D (Pubitemid 28030804)
25. F Ortis N Naamane D Flamez, et al. 2010 Cytokines interleukin-1β and tumor necrosis factor-α regulate different transcriptional and alternative splicing networks in primary β-cells Diabetes 59 358 374 19934004 10.2337/db09-1159 1:CAS:528:DC%2BC3cXhvVyrurg%3D
26. A Hoorens G Stangé D Pavlovic D Pipeleers 2001 Distinction between interleukin-1-induced necrosis and apoptosis of islet cells Diabetes 50 551 557 11246874 10.2337/diabetes.50.3.551 1:CAS:528:DC%2BD3MXhslGhu7Y%3D (Pubitemid 32195219)
27. C Pfleger G Meierhoff H Kolb NC Schloot p520/521 Study Group 2010 Association of T cell reactivity with beta-cell function in recent onset type 1 diabetes patients J Autoimmun 34 127 135 19744828 10.1016/j.jaut.2009.08.004 1:CAS:528:DC%2BC3cXhs1Glsbg%3D
28. C Pfleger A Kaas L Hansen, et al. 2008 Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes Clin Immunol 128 57 65 10.1016/j.clim.2008.03.458 1:CAS:528:DC%2BD1cXnsFOltr4%3D
29. C Pfleger HB Mortensen L Hansen, et al. 2008 Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes Diabetes 57 929 937 18299313 10.2337/db07-1697 1:CAS:528:DC%2BD1cXksVGkurw%3D
30. RD Leslie H Kolb NC Schloot, et al. 2008 Diabetes classification: grey zones, sound and smoke: Action LADA 1 Diab Metab Res Rev 24 511 519 10.1002/dmrr.877 1:STN:280:DC%2BD1cnktF2rtQ%3D%3D
31. N Hosszúfalusi A Vatay K Rajczy, et al. 2003 Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes (LADA) compared with adult-onset type 1 diabetes with rapid progression Diabetes Care 26 452 457 12547879 10.2337/diacare.26.2.452 (Pubitemid 36929072)
32. A Gottsäter M Landin-Olsson P Fernlund A Lernmark G Sundkvist 1993 Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis in type 2 diabetic patients Diabetes Care 16 902 910 8325204 10.2337/diacare.16.6.902 (Pubitemid 23154174)
33. MI Hawa C Thivolet D Mauricio, et al. 2009 Metabolic syndrome and autoimmune diabetes: Action LADA 3 Diabetes Care 32 160 164 18945926 10.2337/dc08-1419
34. CA Meier E Bobbioni C Gabay F Assimacopoulos-Jeannet A Golay JM Dayer 2002 IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin J Clin Endocrinol Metab 87 1184 1188 11889184 10.1210/jc.87.3.1184 1:CAS:528:DC%2BD38XitlWguro%3D (Pubitemid 36121085)
35. P Dandona R Weinstock K Thusu E Abdel-Rahman A Aljada T Wadden 1998 Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss J Clin Endocrinol Metab 83 2907 2910 9709967 10.1210/jc.83.8.2907 1:CAS:528: DyaK1cXltlajsr8%3D (Pubitemid 28493796)
36. SE Shoelson L Herrero A Naaz 2007 Obesity, inflammation, and insulin resistance Gastroenterology 132 2169 2180 17498510 10.1053/j.gastro.2007.03.059 1:CAS:528:DC%2BD2sXmsVyns7w%3D (Pubitemid 46693756)
37. SE Shoelson AB Goldfine 2009 Getting away from glucose: fanning the flames of obesity-induced inflammation Nat Med 15 373 374 19350009 10.1038/nm0409-373 1:CAS:528:DC%2BD1MXktVKgsb0%3D
38. O Rolandsson JP Palmer 2010 Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes Diabetologia 53 1250 1253 20336277 10.1007/s00125-010-1713-0 1:STN:280:DC%2BC3czmsFKjtg%3D%3D
39. AD Pradhan JAE Manson N Rifai JE Buring Ridker 2001 C-reactive Protein, Interleukin-6, and risk of developing type 2 diabetes mellitus JAMA 286 327 334 11466099 10.1001/jama.286.3.327 1:STN:280:DC%2BD3MvisVCmug%3D%3D (Pubitemid 32656163)
40. S Devaraj N Glaser S Griffen J Wang-Polagruto E Miguelino I Jialal 2006 Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes Diabetes 55 774 779 16505242 10.2337/diabetes.55.03.06.db05-1417 1:CAS:528:DC%2BD28XisVWisLs%3D (Pubitemid 43343235)
41. S Basu A Larsson J Vessby B Vessby C Berne 2005 Type 1 diabetes is associated with increased cyclooxygenase and cytokine-mediated inflammation Diab Care 28 1371 1375 10.2337/diacare.28.6.1371 1:CAS:528:DC%2BD2MXlsFyht7c%3D (Pubitemid 40756699)
42. M Trøseid I Seljeflot EM Hjerkinn H Arnesen 2009 Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia Diabetes Care 32 486 492 19092166 10.2337/dc08-1710
43. A Hartkamp R Geenen M Bijl AA Kruize GL Godaert RH Derksen 2004 Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome Ann Rheum Dis 63 1335 1337 15361396 10.1136/ard.2003.011825 1:CAS:528:DC%2BD2cXovFOms70%3D (Pubitemid 39273518)
44. M Mysliwiec K Zorena A Balcerska J Mysliwska P Lipowski K Raczynska 2006 The activity of N-acetyl-beta-D-glucosaminidase and tumour necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children Clin Biochem 39 851 856 16696964 10.1016/j.clinbiochem.2006.03.013 1:CAS:528:DC%2BD28XotlKlur8%3D (Pubitemid 44201188)
45. MR Weihrauch O Manzke M Beyer, et al. 2005 Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease potential for a prognostic factor Cancer Res 65 5516 5519 15994922 10.1158/0008-5472.CAN-05-0100 1:CAS:528:DC%2BD2MXlslOqsro%3D (Pubitemid 40911150)